Terms: = Leukemia AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
396 results:
1. Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children.
Zhang N; Li H; Wang D; Wang Z; Zhu JS; Chen K; Jiang H; Shao JB; Cai C
Clin Epigenetics; 2024 May; 16(1):63. PubMed ID: 38725010
[TBL] [Abstract] [Full Text] [Related]
2. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study.
Guo W; Zhao L; Huang W; Chen J; Zhong T; Yan S; Hu W; Zeng F; Peng C; Yan H
Cardiovasc Diabetol; 2024 Apr; 23(1):118. PubMed ID: 38566143
[TBL] [Abstract] [Full Text] [Related]
3. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical Analysis of Infants with Acute Lymphoblastic leukemia (18 cases)].
Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
[TBL] [Abstract] [Full Text] [Related]
5. [Interim results of a multicenter cohort study for Chinese Children leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
6. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
[TBL] [Abstract] [Full Text] [Related]
7. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Wang L; Wu S; Yu G; Sui X; Chu X; Liu X
J Oncol Pharm Pract; 2023 Dec; 29(8):2031-2036. PubMed ID: 37518980
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of the mutation types and dynamics of FLT3-ITD in acute myeloid leukemia.
Koo M; Song IC; Kim J; Kwon GC; Kim SY
Eur J Haematol; 2023 Oct; 111(4):562-572. PubMed ID: 37435718
[TBL] [Abstract] [Full Text] [Related]
9. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
[TBL] [Abstract] [Full Text] [Related]
10. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options.
Saadi MI; Nikandish M; Ghahramani Z; Valandani FM; Ahmadyan M; Hosseini F; Rahimian Z; Jalali H; Tavasolian F; Abdolyousefi EN; Kheradmand N; Ramzi M
J Egypt Natl Canc Inst; 2023 Jun; 35(1):18. PubMed ID: 37332027
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.
Qin Y; Shen K; Liu T; Ma H
BMC Cancer; 2023 Jun; 23(1):527. PubMed ID: 37291515
[TBL] [Abstract] [Full Text] [Related]
12. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
Nagler A; Labopin M; Blaise D; Raiola AM; Corral LL; Bramanti S; Sica S; Kwon M; Koc Y; Pavlu J; Kulagin A; Busca A; Rodríguez AB; Reményi P; Schmid C; Brissot E; Sanz J; Bazarbachi A; Giebel S; Ciceri F; Mohty M
J Hematol Oncol; 2023 May; 16(1):58. PubMed ID: 37248463
[TBL] [Abstract] [Full Text] [Related]
13. First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Balsat M; Alcazer V; Etienne G; Huguet F; Berger M; Cayssials E; Charbonnier A; Escoffre-Barbe M; Johnson-Ansah H; Legros L; Roy L; Delmer A; Ianotto JC; Orvain C; Larosa F; Meunier M; Amé S; Andreoli A; Cony-Makhoul P; Morisset S; Tigaud I; Rea D; Nicolini FE
Leuk Res; 2023 Jul; 130():107308. PubMed ID: 37230027
[TBL] [Abstract] [Full Text] [Related]
14. Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies.
Schorr C; Forindez J; Espinoza-Gutarra M; Mehta R; Grover N; Perna F
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176053
[TBL] [Abstract] [Full Text] [Related]
15. Expression pattern of
Chu X; Wu D; Zhang C; Hu S
Scand J Clin Lab Invest; 2023 Jul; 83(4):207-211. PubMed ID: 37093849
[TBL] [Abstract] [Full Text] [Related]
16. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
17. High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics.
He X; Hu J; Yan C; Liu X; Zhao Y; Yang P; Wang J; Li S; Zhang W; Dong G; Zhang W; Jing H
Cancer Biomark; 2023; 36(3):221-230. PubMed ID: 36938721
[TBL] [Abstract] [Full Text] [Related]
18. Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Orvain C; Chantepie S; Thomas X; Escofrre-Barbe M; Huguet F; Desbrosses Y; Guillerm G; Uzunov M; Leguay T; Barbieux S; Vey N; Chevallier P; Malfuson JV; Lepretre S; Baumann M; Aykut M; Chaib A; Joris M; Zerazhi H; Stussi G; Chapiro J; Berthon C; Bonmati C; Jourdan E; Carp D; Marcais AR; Gallego-Hernanz MP; Vaida I; Bilger K; Villate A; Pasquier F; Chalandon Y; Maury S; Lheritier V; Ifrah N; Dombret H; Boissel N; Hunault-Berger M
Haematologica; 2023 Dec; 108(12):3287-3297. PubMed ID: 36891751
[TBL] [Abstract] [Full Text] [Related]
19. Prognostication refinement in NPM1-mutated acute myeloid leukemia stratified by FLT3-ITD status with different induction doses of cytarabine.
Wang B; Hua X; Zhang J; Gu W; Li H
Cancer Med; 2023 Apr; 12(8):9420-9433. PubMed ID: 36808479
[TBL] [Abstract] [Full Text] [Related]
20. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
Kameda T; Kataoka K; Kamiunten A; Hidaka M; Miyoshi H; Nakano N; Nosaka K; Yoshimitsu M; Yasunaga JI; Kogure Y; Shide K; Miyahara M; Sakamoto T; Akizuki K; Hidaka T; Kubuki Y; Koya J; Kawano N; Yamashita K; Kawano H; Toyama T; Maeda K; Marutsuka K; Imaizumi Y; Kato K; Sugio T; Tokunaga M; Tashiro Y; Takaori-Kondo A; Miyazaki Y; Akashi K; Ishitsuka K; Matsuoka M; Ohshima K; Watanabe T; Kitanaka A; Utsunomiya A; Ogawa S; Shimoda K
Haematologica; 2023 Aug; 108(8):2178-2191. PubMed ID: 36794502
[TBL] [Abstract] [Full Text] [Related]
[Next]
